Projects per year
Fingerprint
Dive into the research topics where Aster Desouter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
AIIFUND84: Continuous monitoring of glycemic variability to predict dys- and hyperglycemia in asymptomatic type 1 diabetes
Keymeulen, B., Desouter, A., Gorus, F., Van de Velde, U. & Uyttenhove, S.
1/04/22 → 31/05/26
Project: Fundamental
-
OZR3630: OZR Back-up mandate: Biomarkers of impending beta cell loss and dysglycemia in asymptomatic type 1 diabetes
1/11/20 → 31/10/21
Project: Fundamental
-
Analyzing Random Forest’s predictive capability for Type 1 Diabetes progression
Cleymans, N. F., Van De Casteele, M., Vandewalle, J., Desouter, A. K., Gorus, F. K. & Barbe, K., 17 Mar 2025, In: IEEE Open Journal of Instrumentation and Measurement. 4, 11 p., 1000211.Research output: Contribution to journal › Article › peer-review
Open AccessFile63 Downloads (Pure) -
Biomarkers of beta cell loss, dysglycemia and responsiveness to immune intervention in (a)symptomatic type 1 diabetes
Desouter, A., 2025, 237 p.Research output: Thesis › PhD Thesis
-
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development
Calhoun, P., Spanbauer, C., Steck, A., Frohnert, B., Herman, M., Keymeulen, B., Veijola, R., Toppari, J., Desouter, A., Gorus, F., Atkinson, M. A., Wilson, D., Pietropaulo, S. & Beck, R., 11 Feb 2025, In: Diabetologia. 68, p. 930-939 10 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis
Desouter, A., Keymeulen, B., Van de Velde, U., Van Dalem, A., Lapauw, B., De Block, C., Gillard, P., Seret, N., Balti, E. V., Van Vooren, E. R. K. P., Staels, W., Van Aken, S., den Brinker, M., Depoorter, S., Marlier, J., Kahya, H. & Gorus, F., 4 Feb 2025, In: Diabetes Care. 48, 4, p. 528-536 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile9 Citations (Scopus)3 Downloads (Pure) -
The stage- and subgroup-specific impact of non-HLA polymorphisms on preclinical type 1 diabetes progression
the Belgian Diabetes Registry, Vandewalle, J., Desouter, A. K., Van der Auwera, B. J., Chapaza, K. B., Nobels, F., Abrams, P., Lebrethon, M. C., Lapauw, B., Keymeulen, B., Gorus, F. K. & Van de Casteele, M., 15 Feb 2025, In: Heliyon. 11, 3, 12 p., e42156.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)
Prizes
-
FWO Strategic Basic Research Aspirant Fellowship
Desouter, Aster (Recipient), 1 Nov 2021
Prize: Fellowship awarded competitively
Activities
-
Fasting proinsulin:C-peptide ratio as minimally invasive alternative to predict development of stage 3 type 1 diabetes: a longitudinal analysis
Aster Desouter (Speaker)
17 Sept 2025Activity: Talk or presentation › Talk or presentation at a conference
-
Correlation of risk subgroups with stages in progression to T1D and responsiveness to immune intervention.
Aster Desouter (Speaker)
13 Apr 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Belgisch Diabetes Register
Aster Desouter (Speaker)
11 Mar 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Continuous monitoring of glycemic variability to predict dys- and hyperglycemia in asymptomatic type 1 diabetes
Aster Desouter (Contributor) & Bart Keymeulen (Recipient)
1 Apr 2022 → 31 Mar 2025Activity: Other › Written proposal
-
Screening en vroegtijdige behandeling van diabetes type 1: waar staan we?
Aster Desouter (Speaker) & Chantal Mathieu (Speaker)
23 Nov 2022Activity: Talk or presentation › Talk at a public lecture/debate
Press/Media
-
Onderhuidse sensor maakt opvolging van diabetes type 1 makkelijker
17/04/25
1 item of Media coverage
Press/Media: Research
Thesis
-
FXR agonist GW4064 protects human beta cells against glucolipotoxicity by FGF19-mediated downregulation of acetyl-coA carboxylase 2 and not by upregulation of stearoyl coenzyme A desaturase
Author: Desouter, A., 2016Supervisor: Hellemans, K. (Promotor)
Student thesis: Master's Thesis